Statistics for Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection
Total visits
| views | |
|---|---|
| Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection | 0 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |